Cortexolone 17α-Propionate Hydrolysis for 21-Monoester Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for preparing cortexolone 17α-propionate suffer from significant formation of 21-monoester impurities, requiring laborious purification processes and are not suitable for industrial scale due to rapid reaction times and non-selective hydrolysis.
Innovation Solution
A hydrolysis process using a dilute solution of acetic acid in the presence of an ortho-ester, with controlled reaction conditions to minimize 21-monoester formation, followed by crystallization in specific solvent mixtures to obtain a novel hydrated crystalline form.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If acid hydrolysis is used to convert ortho-ester to 17-monoester, then the desired product is formed, but 21-monoester impurities are formed as a by-product
Solution Approach 1:
The patent applies parameter changes by carefully controlling the pH of the hydrolysis medium (maintaining pH between 2-4) and using specific buffer systems (acetate buffers) to achieve selective hydrolysis at the 17-position while minimizing 21-position isomerization. This precise parameter control resolves the contradiction by creating optimal conditions for desired selectivity.
Solution Approach 2:
The patent uses buffer systems (particularly acetate buffers) as intermediaries to mediate the hydrolysis reaction. These buffers control the reaction environment and prevent excessive acidification that would lead to 21-monoester formation, thus resolving the selectivity issue without requiring complex purification.
2Productivity
If the hydrolysis reaction time is extended to ensure complete conversion, then more desired product is obtained, but transposition to 21-monoester increases
Solution Approach 1:
The patent applies preliminary action by pre-adjusting the pH and buffer system before initiating hydrolysis, and by maintaining optimal pH conditions throughout the reaction. This prevents 21-monoester formation from the outset, allowing extended reaction times to achieve complete conversion without increasing impurity levels.
Solution Approach 2:
The patent implements feedback control by monitoring pH during hydrolysis and making adjustments to maintain the optimal pH range (2-4). This feedback mechanism ensures that conversion efficiency is maximized while preventing 21-monoester formation, even during extended reaction times.
3Manufacturing precision
If purification procedures such as fractional crystallization or column chromatography are used to isolate 17-monoester, then product purity is improved, but process complexity and product loss increase
Solution Approach 1:
The patent applies the taking out principle by removing the need for complex purification procedures through selective hydrolysis conditions. By controlling pH and using buffer systems, the reaction inherently produces minimal 21-monoester impurities, allowing direct isolation of pure 17-monoester through simple filtration and crystallization without column chromatography.
Solution Approach 2:
The patent replaces expensive and complex purification equipment (column chromatography systems) with simple, inexpensive operations (filtration, crystallization). This substitution maintains product purity while dramatically reducing process complexity and equipment requirements.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Reduces 21-monoester impurities to less than 3%, enabling industrial scalability and producing a novel hydrated crystalline form with distinct XRPD and IR characteristics.
Implementation Method 1
a) ortho-esterification of cortexolone of formula (II) in the presence of a reagent selected from triethyl orthopropionate and trimethyl orthopropionate to provide the corresponding ortho-ester of formula (III) b) hydrolysis of the ortho-ester of formula (III) in the presence of a dilute solution of acetic acid to provide to desired cortexolone 17α-propionate of formula (I)
Implementation Method 2
crystallization in specific solvent mixtures to obtain a novel hydrated crystalline form
Data Source
AI summary
The present invention is directed to a process for the preparation of cortexolone 17α-propionate, comprising a hydrolysis reaction of an ortho-ester of formula (III)in which R is a hydrogen atom or a methyl group,in the presence of a dilute solution of acetic acid.The present invention is also directed to a hydrated crystalline form of cortexolone 17α-propionate obtained by such process.